Resource-efficient decellularization of human iliac arteries using a 3D-printed radial-flow bioreactor: CFD-guided design and experimental validation
Biomedical Materials · 01.06.2026 · 21 (3) · 035015
DOI: 10.1088/1748-605x/ae6aed ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, online erschienen am 22.05.2026. Verfasst von Odin Ramírez-Fernández und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Tecnológica de México-UNITEC México-Campus en Línea, Anáhuac, Ciudad, México, de, 11320, Mexico. Hauptthemen laut MEDLINE: Bioreactors, Iliac Artery, Tissue Engineering, Printing, Three-Dimensional. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Sistema Nacional de Investigadores.
Abstract (Originalsprache)
Vascular bypass and reconstruction often rely on synthetic or allogeneic grafts, which may exhibit limited long-term patency and adverse host responses. Decellularized extracellular matrix scaffolds offer a promising alternative; however, conventional perfusion protocols are frequently reagent-intensive and technically demanding. This study introduces a 3D-printed radial-flow bioreactor designed for the decellularization of human iliac arteries with reduced detergent consumption. Arteries were perfused radially for 8 d using a 1% w·v −1 sodium dodecyl sulfate solution, followed by deoxyribonuclease I treatment and phosphate-buffered saline washes. Decellularization efficacy was quantified by nuclear density using 4′,6-diamidino-2-phenylindole staining, and residual DNA was measured by fluorometric quantification. The radial-flow bioreactor achieved approximately 97% nuclear reduction using 70 ml of detergent solution, compared to 250 ml required by a benchmark perfusion setup. Residual DNA content was reduced to 40 ± 5.2 ng mg −1 , while collagen and elastin retention remained high. Computational fluid dynamics (CFD) revealed a uniform wall shear stress (WSS) distribution along the luminal surface (mean WSS ≈ 0.97 Pa) and a minimal pressure drop (Δ P ≈ 116 Pa) under simulated conditions. These findings provide a mechanistic rationale for the observed performance and support further device optimization. Overall, the proposed radial-flow bioreactor provides a resource-efficient and experimentally validated approach for human iliac artery decellularization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidad Tecnológica de México-UNITEC México-Campus en Línea, Anáhuac, Ciudad, México, de, 11320, Mexico.
- Facultad de Ingeniería Mecánica y Eléctrica U.N., Universidad Autónoma de Coahuila, Barranquilla S/N, Guadalupe, Monclova, Coahuila, 25750, Mexico.
ORCID-Profile: Odin Ramírez-Fernández, Fabián Equihua-Guillén, Jesús Emilio Camporredondo-Saucedo, Laura Guadalupe Castruita-Ávila, Adrián Moises García-Lara
Förderung
- Sistema Nacional de Investigadores
Zitieren
APA
Ramírez-Fernández, O., Equihua-Guillén, F., Camporredondo-Saucedo, J. E., Castruita-Ávila, L. G., & García-Lara, A. M. (2026). Resource-efficient decellularization of human iliac arteries using a 3D-printed radial-flow bioreactor: CFD-guided design and experimental validation. Biomedical Materials, 21(3), 035015. https://doi.org/10.1088/1748-605x/ae6aed
Vancouver
Ramírez-Fernández O, Equihua-Guillén F, Camporredondo-Saucedo JE, Castruita-Ávila LG, García-Lara AM. Resource-efficient decellularization of human iliac arteries using a 3D-printed radial-flow bioreactor: CFD-guided design and experimental validation. Biomedical Materials. 2026;21(3):035015. doi:10.1088/1748-605x/ae6aed
BibTeX
@article{RamrezFernndez2026,
author = {Ramírez-Fernández, Odin and Equihua-Guillén, Fabián and Camporredondo-Saucedo, Jesús Emilio and Castruita-Ávila, Laura Guadalupe and García-Lara, Adrián Moises},
title = {Resource-efficient decellularization of human iliac arteries using a 3D-printed radial-flow bioreactor: CFD-guided design and experimental validation},
journal = {Biomedical Materials},
year = {2026},
volume = {21},
number = {3},
pages = {035015},
doi = {10.1088/1748-605x/ae6aed}
}
EUVIMED